Abstract:BC‐specific sEV network was characterized by enriched cell adhesion and immunomodulatory molecules, in which the contribution of CAFs was highlighted. BC tissue‐derived sEVs presented a stronger immunostimulatory function than in vitro models. Moreover, some noncancer cell‐derived sEV biomarkers in circulation have great diagnostic potential. Small extracellular vesicles (sEVs) are essential mediators of intercellular communication within the tumor microenvironment (TME). Although the biological features of sEVs have been characterized based on in vitro culture models, recent evidence indicates significant differences between sEVs derived from tissue and those derived from in vitro models in terms of both content and biological function. However, comprehensive comparisons and functional analyses are still limited. Here, we collected sEVs from breast cancer tissues (T‐sEVs), paired normal tissues (N‐sEVs), corresponding plasma (B‐sEVs), and tumor organoids (O‐sEVs) to characterize their transcriptomic and proteomic profiles. We identified the actual cancer‐specific sEV signatures characterized by enriched cell adhesion and immunomodulatory molecules. Furthermore, we revealed the significant contribution of cancer‐associated fibroblasts in the sEV network within the TME. In vitro model‐derived sEVs did not entirely inherit the extracellular matrix‐ and immunity regulation‐related features of T‐sEVs. Also, we demonstrated the greater immunostimulatory ability of T‐sEVs on macrophages and CD8+ T cells compared to O‐sEVs. Moreover, certain sEV biomarkers derived from noncancer cells in the circulation exhibited promising diagnostic potential. This study provides valuable insights into the functional characteristics of tumor tissue‐derived sEVs, highlighting their potential as diagnostic markers and therapeutic agents for breast cancer.

Tumor-derived small extracellular vesicles promote breast cancer progression by upregulating PD-L1 expression in macrophages

Colorectal Cancer‐Derived Small Extracellular Vesicles Promote Tumor Immune Evasion by Upregulating PD‐L1 Expression in Tumor‐Associated Macrophages

Tumor-promoting mechanisms of macrophage-derived extracellular vesicles-enclosed microRNA-660 in breast cancer progression

Colorectal Cancer‐Derived Small Extracellular Vesicles Promote Tumor Immune Evasion by Upregulating PD‐L1 Expression in Tumor‐Associated Macrophages (adv. Sci. 9/2022)

Tumor-Derived Extracellular Vesicles Regulate Cancer Progression in the Tumor Microenvironment

Membrane Protein Modification Modulates Big and Small Extracellular Vesicle Biodistribution and Tumorigenic Potential in Breast Cancers in vivo

Integrated transcriptomics, proteomics, and functional analysis to characterize the tissue‐specific small extracellular vesicle network of breast cancer

Tumor Cell–released LC3‐positive EVs Promote Lung Metastasis of Breast Cancer Through Enhancing Premetastatic Niche Formation

Tumor-Derived RAB21+ABHD12+ sEVs Drive the Premetastatic Microenvironment in the Lung

The interplay between the tumor microenvironment and tumor-derived small extracellular vesicles in cancer development and therapeutic response

Chemotherapy-Induced Upregulation of Small Extracellular Vesicle-Associated PTX3 Accelerates Breast Cancer Metastasis

Modulatory effects of cancer stem cell-derived extracellular vesicles on the tumor immune microenvironment

Preferential Release of microRNAs via Extracellular Vesicles is Associated with Ductal Carcinoma In Situ to Invasive Breast Cancer Progression

Small extracellular vesicles promote the formation of the pre-metastatic niche through multiple mechanisms in colorectal cancer

The roles of small extracellular vesicles in cancer and immune regulation and translational potential in cancer therapy

Tumor Extracellular Vesicles Regulate Macrophage-Driven Metastasis through CCL5

Tumor-derived extracellular vesicles regulate macrophage polarization: role and therapeutic perspectives

Extracellular vesicles in the treatment and diagnosis of breast cancer: a status update

Extracellular vesicles remodel tumor environment for cancer immunotherapy

Tumor-derived extracellular vesicles in breast cancer: From bench to bedside

Ovarian cancer derived extracellular vesicles promote the cancer progression and angiogenesis by mediating M2 macrophages polarization